Radiotherapy Outcomes in Mesothelioma Linked to Pembrolizumab
Canadian researchers say radiotherapy may hold the key to improving outcomes in mesothelioma. Mesothelioma is a fast-growing membrane cancer caused…
-
-
Clinical Trial Participation: Perspectives from Mesothelioma Patients and Caregivers
Clinical trial participation is a common topic for mesothelioma patients and their caregivers. Treatment options for mesothelioma are increasing. This… -
First-Line Chemotherapy versus Immunotherapy versus Maintenance Therapy
A recent study compared mesothelioma patients’ survival by physician’s choice of treatment. Is first-line chemotherapy the best choice? Malignant pleural… -
Immunotherapeutic and Targeted Approaches to Mesothelioma Treatment
Immunotherapeutic and targeted approaches might make mesothelioma more responsive to chemotherapy. Malignant pleural mesothelioma is an aggressive disease. Asbestos exposure… -
Precision Medicine Treatment: Gene-Targeting Mesothelioma
A new precision medicine treatment for mesothelioma comes from scientists in Italy. This form of mesothelioma occurs after asbestos exposure… -
Radiation Therapy for Mesothelioma Patients: Value and Timing
The value and safety of radiation therapy for mesothelioma patients are promising. Oncologists from the Fox Chase Cancer Center released… -
Asbestos Exposure in Construction Workers Leads to Mesothelioma
Asbestos exposure in construction workers remains a particular concern. Malignant mesothelioma is a rare cancer with a global incidence. Italy… -
Nivolumab + Ipilimumab Provides Long-Term Survival Benefit in Malignant Pleural Mesothelioma
Nivolumab + ipilimumab continues to provide a long-term survival benefit in malignant pleural mesothelioma. A new report shows a 3-year… -
-
Two New Diagnostic Tissue Biomarkers Discovered for Mesothelioma
Scientists have now identified two new diagnostic tissue biomarkers for malignant pleural mesothelioma. Doctors identify mesothelioma using diagnostic tissue biomarkers.…
